About entimo

Your tech ally for fast and compliant clinical research

We support scientific rigor and speed research by lifting the compliance burden from researchers’ shoulders.
Contact us

Entimo AG is a German life sciences informatics company that provides software solutions and services to biopharmaceutical and contract research organizations. Our software and services address regulatory requirements in clinical research and development.

We use state-of-the art technical approaches to meet current challenges, and adaptable methods that anticipate future needs in the biopharmaceutical and life sciences sector. We provide our customers top-quality engineering, powerful tools, and the best possible customer support.

Headquartered in
Berlin, Germany
Continuously growing since
2002
Colleagues from
17 nationalities
Delivered at key events
50+ PHUSE presentations
For scope 1 and 2 emissions
Net zero since 2024

Our values

Innovation without disruption

We help to streamline and optimize systems and processes, enhancing them continuously and building lasting value. At the same time, our commitment to quality and strict standards ensures that every line of code, every feature, and every user interface reflects precision and performance. Our ongoing innovation is sustaining and empowers our customers to advance clinical data science with confidence.

Commitment to success

Clinical breakthroughs depend on tools that work without causing a burden. We understand the weight of the trust our customers place in us, and the responsibility that comes with supporting life-changing research. Our promise is simple and we keep it: We deliver solutions that are reliable, thoughtfully designed, and easy to integrate. So that you can focus on data science and successful submissions.

Constant collaboration

Software does not solve problems on its own—people and experience do. We collaborate closely with our customers and the clinical community—listening carefully to build tools that help clinical data scientists in making a real impact to address patients’ needs. Our long-lasting relationships with customers are grounded in empathy, decades of experience and shared purpose.

Our milestones

  • 2002 Founding as a spin-off from Condat AG

    In 2002, a small and ambitious team of innovators spun off from Condat AG, a company about to be acquired by Texas Instruments. This team, deeply embedded in the pharmaceutical sector, realized that there is strong industry demand for a configurable, off-the-shelf solution that could adapt to the needs of the life sciences industry without the repetitive grunt work of custom builds.

  • 2003 ISO 9001 Certification

    The initial version of the entimo Quality Management System was released and received the ISO 9001 certification, which has been maintained ever since through annual audits and bi-annual re-certifications, showcasing entimo’s commitment to quality and compliance.

  • 2004 Entimo headcount grows by 30%

    Through successful hires in 2004, the entimo team grew by more than 30% within one year.

  • 2005 Macro system maintanance

    entimo takes over maintenance and development activities for all gobal SAS macro systems for a pharma customer.

  • 2006 entimICE DARE project launched

    After two years of internal research and development that formed the essential technological foundation, entimo decided to launch the commercial product development of entimICE DARE, one of the first off-the-shelf Clinical Data Repositories and Statistical Computing Environments.

  • 2007 entimo becomes PHUSE sponsor

    entimo joins PHUSE as sponsor, exhibitor and presenter at the PHUSE EU Connect in Lisbon, a beginning of a long and exciting engagement.

  • 2008 entimo becomes CDISC Gold Member

    entimo has implemented CDISC standards in scope of products and professional services for years and finally decided to become a CDISC Gold Member.

  • 2009 First entimICE components customer

    A first industry customer out of the top 10 global pharma became aware of the configurable entimICE DARE product and decided to make use of some configurable components in scope of a custom solution for clinical trial deliverable tracking.

  • 2010 First entimICE DARE customer

    A global CRO recognized the potential of entimICE DARE and became our first major client.

  • 2011 Office expansion

    entimo requires more space for the growing team and expands its office space by another +25% in a sustainable office building in central Berlin.

  • 2012 Cooperation with NNIT

    NNIT and entimo form an official partnership to support the growth of entimICE products and of NNIT's professional service offerings.

  • 2013 8 of the top 50 are using entimICE DARE

    By 2013, we had gained the trust of eight of the top 50 Big Pharma companies.

  • 2014 10+ entimICE DARE customers

    entimo is proud to welcome customers #10 and #11 in the user community in 2014.

  • 2015 First entimICE DARE User Group Meeting

    entimo invites all customers to a vibrant two-day event to Berlin to review customer-specific implementations and use cases, exchange experiences, and craft the roadmap together

  • 2016 First upgrade to 300 concurrent users

    Many entimICE DARE customers had growing user numbers after go-live, with the first customer cracking 300 concurrent users and thousands of named users in 2016.

  • 2017 First cloud deployment

    entimo and a US-based pharma engaged in a project to lift and shift their entimICE DARE platform from an on-premise setting into the cloud, including a working integration with AWS redshift for real-world evidence use cases.

  • 2018 First APAC-based entimICE DARE customer

    Another top 50 pharma company and one of the biggest players in Japan decides to implement entimICE DARE as their central Clinical Data Repository and Statistical Computing Environment

  • 2019 entimICE FastTrack development launched

    entimo is building a Statistical Computing Environment to meet future needs and take best advantage of advancing technology.

  • 2020 New Board of Directors

    Sven Prasse and Marc Jantke are the new Board of Directors elected by the Supervisory Board, following in the big footsteps of Dr. Marianne Neumann and Jürgen Spieler, who led the company for 18 years and will remain closely connected with the company.

  • 2021 entimICE DARE most used SCE

    In a survey presented at the PHUSE EU Connect 2021 by an independent third party, entimICE DARE was shown as the most widely known and used Statistical Computing Environment.

  • 2022 First entimICE FastTrack customer

    Only one year after the first market release, one of the global top 50 pharma companies adopts entimICE FastTrack as their new CDR and SCE for all emerging market activities.

  • 2023 Second entimICE FastTrack customer

    One of the biggest generics and biosimilars producers in the world adopts entimICE FastTrack for all trials and research activities as their new CDR and SCE.

  • 2024 entimo becomes Posit Reseller

    Posit and entimo engage in a Reseller agreement allowing entimo to provide Posit licenses to the market in conjunction with entimICE FastTrack.

  • 2025 First migration from entimICE DARE to entimICE FastTrack

    A long-term customer of entimICE DARE (one of the top 50 global pharma companies) transitions with all their data and metadata to entimICE FastTrack.

Our leadership

Marc Jantke, Managing Director and CEO

Marc Jantke

Managing Director | CEO | with entimo since 2004

Our teams value the flexible and friendly work environment with options to grow their talents. This enables us to drive meaningful innovations for our products and services without ever compromising our highest standards regarding quality and compliance.

Marc Jantke

Managing Director | CEO | with entimo since 2004

Marc Jantke

Managing Director | CEO | with entimo since 2004
Marc Jantke, Managing Director and CEO

Our teams value the flexible and friendly work environment with options to grow their talents. This enables us to drive meaningful innovations for our products and services without ever compromising our highest standards regarding quality and compliance.

  • Marc oversees product development, marketing, sales and partners at entimo.
  • Before joining the Board in 2020, Marc managed the regulatory-compliant product development and led the agile transformation at entimo.
  • Marc has a Master’s degree in Medical Informatics from the University of Heidelberg.
Sven Prasse, Managing Director and COO

Sven Prasse

Managing Director | COO | with entimo since 2002

At entimo, we combine an agile mindset with expert software development and clinical R&D experience. We have been trusted partners for decades, building and maintaining regulatory-compliant solutions for today and the future.

Sven Prasse

Managing Director | COO | with entimo since 2002

Sven Prasse

Managing Director | COO | with entimo since 2002
Sven Prasse, Managing Director and COO

At entimo, we combine an agile mindset with expert software development and clinical R&D experience. We have been trusted partners for decades, building and maintaining regulatory compliant solutions for today and the future.

  • Sven oversees operations, professional services, finance and administration at entimo.
  • Before becoming Managing Director in 2020, Sven managed various enterprise service projects in GxP-regulated environments for pharmaceutical research and development.
  • Sven has a Master’s degree in Computer Science from the Technical University of Berlin.